Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Alemtuzumab Treatment for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS): Preliminary Results.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, MD, Young-Shin Lee, RN, Soo-Kyung Sim, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 1464.

https://doi.org/10.1182/blood.V110.11.1464.1464

Published: 2007

Journal Articles

C3435T Polymorphism of MDR1 Gene Is Not Associated with p-Glycoprotein Function of Leukemic Blasts and Clinical Outcomes in Patients with Acute Myeloid Leukemia.

Michael Jinpyo Lee, Eun-Hye Hur, MS, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun-Hee Kim, RN, Hee-Jung Lee, RN, Ip-Sol Kang, RN, Kyung-Soo Shim, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Young-Shin Lee, RN, Chan-Jeoung Park, MD, Hyung-Sook Chi, MD, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 2381.

https://doi.org/10.1182/blood.V110.11.2381.2381

Published: 2007

Journal Articles

Efficacy Comparison of Oral Versus Intravenous Busulfan in a BuCy Conditioning Regimen for Allogeneic BMT.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Young-Shin Lee, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 5042.

https://doi.org/10.1182/blood.V110.11.5042.5042

Published: 2007

Journal Articles

Treatment of Intractable Graft-Versus-Host Disease with Bone Marrow Derived Mesenchymal Stem Cells - A Pilot Clinical Trial.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Young-Shin Lee, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 4974.

https://doi.org/10.1182/blood.V110.11.4974.4974

Published: 2007

Journal Articles

HLA-Haploidentical Familial Donor Hematopoietic Cell Transplantation without Ex Vivo- T Cell Depletion after Reduced-Intensity Conditioning of Busulfan, Fludarabine, and Anti-Thymocyte Globulin: A Preliminary Report.

Kyoo-Hyung Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Ho-Jin Shin, MD, Young-Shin Lee, RN, Young-Ah Kang, RN, Miee Seol, RN, Seong-Gil Ryu, BS, Je-Hwan Lee, MD

Blood (2007) 110 (11): 3077.

https://doi.org/10.1182/blood.V110.11.3077.3077

Published: 2007

NARROW

Alemtuzumab Treatment for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS): Preliminary Results.

C3435T Polymorphism of MDR1 Gene Is Not Associated with p-Glycoprotein Function of Leukemic Blasts and Clinical Outcomes in Patients with Acute Myeloid Leukemia.

Efficacy Comparison of Oral Versus Intravenous Busulfan in a BuCy Conditioning Regimen for Allogeneic BMT.

Treatment of Intractable Graft-Versus-Host Disease with Bone Marrow Derived Mesenchymal Stem Cells - A Pilot Clinical Trial.

HLA-Haploidentical Familial Donor Hematopoietic Cell Transplantation without Ex Vivo- T Cell Depletion after Reduced-Intensity Conditioning of Busulfan, Fludarabine, and Anti-Thymocyte Globulin: A Preliminary Report.

Email alerts

ASH Publications

American Society of Hematology

Alemtuzumab Treatment for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS): Preliminary Results.

C3435T Polymorphism of MDR1 Gene Is Not Associated with p-Glycoprotein Function of Leukemic Blasts and Clinical Outcomes in Patients with Acute Myeloid Leukemia.

Efficacy Comparison of Oral Versus Intravenous Busulfan in a BuCy Conditioning Regimen for Allogeneic BMT.

Treatment of Intractable Graft-Versus-Host Disease with Bone Marrow Derived Mesenchymal Stem Cells - A Pilot Clinical Trial.

HLA-Haploidentical Familial Donor Hematopoietic Cell Transplantation without Ex Vivo- T Cell Depletion after Reduced-Intensity Conditioning of Busulfan, Fludarabine, and Anti-Thymocyte Globulin: A Preliminary Report.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only